Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
06/2003
06/05/2003WO2003045324A2 14-methyl-epothilones
06/05/2003WO2003045313A2 2-aminoquinoline compounds
06/05/2003WO2002048124A3 Piperazine derivatives
06/05/2003US20030105336 Pyrazole derivatives, their preparation and their use in pharmaceuticals
06/05/2003US20030105333 RXR activating molecules
06/05/2003US20030105330 Synthesis of epothilones, intermediates thereto and analogues thereof
06/05/2003US20030105147 Analgesics, sedatives, anesthetics
06/05/2003US20030105139 Indole derivatives as 5-HT receptor antagonist
06/05/2003US20030105133 4-Substituted piperidine analogs and their use as subtype selective NMDA receptor, antagonists
06/05/2003US20030105124 Substituted benzolactam compounds
06/05/2003US20030105111 For use as fluorescence dyes and probes
06/05/2003US20030105106 5-HT receptor ligands and uses thereof
06/05/2003US20030105090 For therapy of cancer, diabetes
06/05/2003US20030105085 Antagonists of MCP-1 function and methods of use thereof
06/05/2003US20030105074 Phthalazine compounds and therapeutic agents for erectile dysfunction
06/05/2003US20030105071 For therapy of addiction, anxiety, depression, sexual dysfunction, hypertension, migraine, Alzheimer's disease, obesity, emesis, psychosis, analgesia, schizophrenia, Parkinson's disease, restless leg syndrome, sleeping disorders
06/05/2003US20030104974 Dual inhibitorsof PDE 7 and PDE 4
06/05/2003US20030104324 Yellow coupler and silver halide color photographic lightsensitive material containing the same
06/05/2003US20030104082 Microbe inhibitors comprising antimicrobial isolates, botanical extracts or phytochemicals; also Commiphora myrrha, Commiphora molmol, Commiphora erythraea, sequiterpenes, nutrient, a vitamin, or a vitamin B complex.
06/05/2003CA2468716A1 Heterocyclic amide compounds as apolipoprotein b inhibitors
06/05/2003CA2468184A1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
06/05/2003CA2468015A1 2-aminoquinoline compounds
06/05/2003CA2467825A1 Benzothiazole derivatives
06/05/2003CA2467565A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
06/04/2003EP1315733A2 Method for producing anellated tetrahydro-[1h]-triazoles
06/04/2003EP1315724A1 A thiazolidinedione derivative and its use as antidiabetic
06/04/2003EP1315723A1 The hydrochloride salt of 5[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
06/04/2003EP1315722A1 Thiazolidinone nitrate salt
06/04/2003EP1315721A1 A thiazolidinedione derivative and its use as antidiabetic
06/04/2003EP1315698A1 Pyrrolidines as inhibitors of neuraminidases
06/04/2003EP1315500A1 Pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors
06/04/2003EP1252150B1 Heterocyclic derivatives, preparation method and pharmaceutical compositions containing same
06/04/2003EP1155014B1 New benzimidazole compounds for use as active therapeutic substances, process for the preparation of these compoudns and pharmaceutical compositions comprising them
06/04/2003EP1144407B1 Cyclic guanidine derivatives and their use as pesticides
06/04/2003EP1084127B1 Organometallic complex molecule and organic electroluminescent device using the same
06/04/2003EP0944616B1 Bicyclic aryl carboxamides and their therapeutic use
06/04/2003EP0901487B1 2,3,6 trisubstituted-4(3h)-quinazolinones
06/04/2003EP0863875B1 New 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency
06/04/2003EP0820452B1 Carbonyl-piperazinyl and piperidinil compounds which inhibit farnesyl protein transferase
06/04/2003EP0809637B1 Fungicidal aza-heterocycloalkenes
06/04/2003EP0783507B1 Compounds useful as antiproliferative agents and garft inhibitors
06/04/2003CN1422267A Processes for the preparation of thiazolidinedione derivatives and intermediates
06/04/2003CN1422262A 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
06/04/2003CN1110497C Di-or triaza-spiral [4,5] decane derivative
06/04/2003CN1110495C Arylalkyl diazinones, its preparing method and its medical preparation
06/04/2003CN1110484C 2-(cary lphenyl) amino-imidazoline derivatives
06/03/2003US6573277 Metalloproteinase inhibitor
06/03/2003US6573270 Endothelin receptor antagonists
06/03/2003US6573268 Administering novel azolidinedione derivatives, tautomers, stereoisomers, polymorphs, pharmaceutically acceptable salts and solvates to treat diabetes
06/03/2003US6573264 Heteroaryl alkyl piperazine derivatives
06/03/2003US6573262 Compounds for treating mammals infected with HIV virus
06/03/2003US6573252 Therapy and prevention of bony disorders; improved gastrointestinal tolerability
06/03/2003CA2251912C Inclusion complexes of aryl-heterocyclic salts
06/03/2003CA2223625C Substituted n-(indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors
06/03/2003CA2053954C Process for the preparation of nitroguanidine derivatives
05/2003
05/30/2003WO2003044015A2 Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors
05/30/2003WO2003044014A1 Indole-2-carboxamides as factor xa inhibitors
05/30/2003WO2003044000A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/30/2003WO2003043999A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/30/2003WO2003043998A1 N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders, cancer, and other diseases
05/30/2003WO2003043988A1 Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient
05/30/2003WO2003043985A1 Heterocyclic compounds and methods of use
05/30/2003WO2003043983A1 Piperazine derivatives destabilising androgen receptors
05/30/2003WO2003043980A1 Azetidinyl diamines useful as ligands of the nociceptin receptor orl-1
05/30/2003WO2003043636A1 Nicotin-or isonicotin benzothiazole derivatives
05/30/2003WO2003043634A1 Benzothiazole derivatives as adenosine receptor ligands
05/30/2003WO2003010141A3 Hepatitis c virus polymerase inhibitors with a heterobicyclic structure
05/30/2003WO2003005824B1 Substituted 3-heteroaryl (amino-or-oxy)-pyrrolidin-2-ones, method for the production thereof and use thereof as herbicides or as plant growth regulators
05/30/2003WO2002070739A3 Assay for identifying inhibitors of the rna dependent rna polymerase (ns5b) of hcv
05/30/2003WO2002070509A3 Antagonists of mcp-1 function and methods of use thereof
05/30/2003WO2002036116A9 Tripeptidyl peptidase inhibitors
05/30/2003CA2467752A1 Piperidin-2-one derivative compounds and pharmaceutical composition comprising the same as active ingredient
05/30/2003CA2467551A1 Benzothiazole derivatives as adenosine receptor ligands
05/30/2003CA2466925A1 Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors
05/30/2003CA2466491A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/29/2003US20030100774 Process for synthesis of 2-yl chroman derivatives
05/29/2003US20030100770 D-proline derivatives
05/29/2003US20030100769 Such s 2-(6-chloro-3-pyridyl)-2-imidazoline which has good affinity for and activate alpha-4-beta-2-nicotinic acetyl-choline receptors; for treatment and prevention of neuro-degenerative disorders (Alzheimer's/Parkinson's disease)
05/29/2003US20030100757 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1H-indole derivatives interacting with the dopamine D4 receptor
05/29/2003US20030100755 For example (2S, 3S, 5S)-2-(2,6-dimethylphenoxyacetyl)amino-3-hydroxy-5-(2S-(1-tetrahydro-pyrimid-2-onyl)-3-methyl butanoyl)amino-1,6-diphenylhexane; HIV therapy
05/29/2003US20030100751 Coupling condensation synthesis of heterocycles
05/29/2003US20030100582 Benzimidazole compounds for regulating IgE
05/29/2003US20030100571 Such as 2-((6-(((4-(3,4-dimethoxyphenyl)methyl)amino)-7-ethyl-7H-purin-2-yl)amino) -4,5-methyl-N-phenyl-5-thiazole-carboxamide for treatment of lymphocyte mediated diseases such as transplant rejection and graft versus host disease
05/29/2003US20030100567 Tyrosine kinase inhibitors
05/29/2003US20030100545 Psychological disorder treatments that increase the activity of cholinergic receptors
05/29/2003US20030100088 Protease inhibitor conjugates and antibodies useful in immunoassay
05/29/2003US20030100018 Mass-based encoding and qualitative analysis of combinatorial libraries
05/28/2003EP1314981A2 Benzo[c,d]indole-fluorochromes for labelling biomolecules and polymer particles
05/28/2003EP1314733A1 Indole-2-carboxamides as factor Xa inhibitors
05/28/2003EP1314732A2 Substituted pyrimidine compounds and their use
05/28/2003EP1314731A2 Substituted pyrimidine compounds and their use
05/28/2003EP1314426A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
05/28/2003EP1313726A1 Quinoline derivatives having vegf inhibiting activity
05/28/2003EP1313711A2 Indazole derivatives as jnk inhibitors
05/28/2003EP1313710A1 Pyrazole derivatives and their use as protein kinase inhibitors
05/28/2003EP1313477A1 Compounds and methods
05/28/2003EP1313471A1 Benzylidene thiazolidinediones and their use as antimycotic agents
05/28/2003EP1231211B1 Thiazolidinedione derivatives as antidiabetic agents
05/28/2003EP1175419B1 Aryl sulfonyls as factor xa inhibitors
05/28/2003EP1065205B1 Heteroaromatic derivatives
1 ... 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 ... 628